Hubei Xindesheng CPHI made its debut, and the exchange heat at the booth increased

The 24th CPHI China 2026, together with the 19th PMEC China 2026, officially kicked off on June 16th at the Shanghai New International Expo Center. The exhibition will last for three days, with a display area of over 250000 square meters, gathering more than 3700 exhibitors from home and abroad, covering more than 180 countries and regions, and is expected to attract over 110000 professional visitors.

Concentrated presentation of the entire industry chain ecosystem

This exhibition has set up multiple special zones to comprehensively showcase the complete industry chain ecology from drug research and development, raw material production to formulation manufacturing, packaging and transportation. The cutting-edge technology and innovative achievements exhibition area of W9 Hall covers antibodies CGT, Innovative drug technology services such as peptides and nucleic acid drugs; The W16 Smart Laboratory space presents immersive real-life laboratory automation, intelligent sample processing, and other digital solutions. The traditional Chinese medicine and herbal medicine sections of Hall E5, the medical beauty packaging materials section of Hall E8, and the drug and equipment combination section of Hall N6 are simultaneously open, providing opportunities for audiences from different segmented fields to learn about industry trends. During the exhibition, multiple technical seminars and supply and demand matching activities were also held, covering hot topics such as biotechnology development, laboratory automation, and internationalization of active pharmaceutical ingredients.

New Desheng booth communication heat rises

Hubei Xindesheng Material Technology Co., Ltd. showcased its core product lineup at this exhibition, with its booth located in the IVD core raw material exhibition area. The company dispatched a professional team of 6 people to be stationed throughout the entire process, engaging in face-to-face communication with new and old customers from both domestic and overseas. Since its launch, the New Desheng booth has attracted numerous professional visitors to stop and inquire. Among the visiting clients are both long-term IVD reagent manufacturers, overseas buyers who have had their first contact with the company's products, and customer representatives from Southeast Asia, the Middle East, Europe, and other regions. The negotiation mainly focuses on the technical parameters, customized requirements, and supply chain guarantee of biological buffering agents (Tris base, HEPES, MOPS, PIPES, etc.), chemiluminescence reagents (luminol, isoluminol, acridine ester, etc.), chromogenic substrates, enzyme preparations, and blood collection tube additives.

Huanggang new factory is about to start production, attracting attention

Several customers have shown strong interest in the new production base of Hubei Xindesheng located in Huanggang. The new base will be officially put into operation in July 2026, with dozens of customized large-scale reaction vessels in place, greatly expanding the production capacity of biological buffering agents and IVD core raw materials. After production, the scale production capacity, raw material quality control level, and large-scale order delivery capability will achieve a leapfrog improvement, better responding to the continuously growing raw material demand in domestic and foreign markets. Many customers have had in-depth discussions with the team regarding the production capacity scale, product line expansion, and future supply stability of the new base, hoping to establish a closer cooperative relationship after the new factory is put into operation.

Continuous communication cordially invites you to visit

The exhibition is still in full swing and will continue until June 18th. As a professional supplier with nearly 20 years of deep cultivation in the field of IVD core raw materials, Hubei Xindesheng further demonstrated its research and development strength and production capacity layout in the fields of biological buffering agents and IVD core raw materials through this exhibition. The New Desheng team welcomes more industry colleagues to visit the booth for exchange and guidance. Whether it is IVD reagent manufacturers seeking stable supply or R&D personnel focusing on upstream raw material technology innovation, they can conduct in-depth discussions on product applications, technical difficulties, and cooperation models. New Desheng will continue to provide reliable upstream raw material solutions for the pharmaceutical and in vitro diagnostic industries.